Purine derivatives as kinase inhibitors
Details for Australian Patent Application No. 2003215325 (hide)
International Classifications
Event Publications
31 July 2003 Complete Application Filed
Priority application(s): 60/362,245 05.03.02 US
30 October 2003 Application Open to Public Inspection
Published as AU-B-2003215325
18 September 2008 Application Accepted
Published as AU-B-2003215325
9 October 2008 Corrigenda
Applications Accepted - Name Index Under the name Eli Lilly and Company, Application No. 2003215325, under INID(72), correct the co inventor name to Berridge, Brian Raymond, Ruegg, Charles Edwards and Sullivan, John Morris
22 January 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003215326-METHOD FOR CLEANING HOLLOW TUBING AND FIBERS
2003215324-SYSTEM AND METHOD FOR BROADBAND DIGITAL BROADCASTING
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser